GGrantIndex
← Search

DEVELOPMENT OF ANTI-PROSTATE-SPECIFIC MEMBRANE ANTIGEN-DUOCARMICIN CONJUGATES FOR TARGETED DEVELOPMENT OF ADVANCED CASTRATE RESISTANT PROSTATE CANCER

$1,259,966FY2011Department of the ArmyDOD

Weill Medical College Of Cornell University

Investigators

View source on USAspending →
DEVELOPMENT OF ANTI-PROSTATE-SPECIFIC MEMBRANE ANTIGEN-DUOCARMICIN CONJUGATES FOR TARGETED DEVELOPMENT OF ADVANCED CASTRATE RESISTANT PROSTATE CANCER · GrantIndex